Early legislative language from the House of Representatives on the newest COVID-19 stimulus bill includes a provision to remove the "rebate cap" in Medicaid. That has the potential to put drugmakers in a position where they are paying states every time certain medicines are prescribed. We interview West Health's Sean Dickson to understand how the program works and what the implications will be if the measure becomes law.